Diagnostic markers for ovarian cancer screening: not ready for routine clinical use.

To the Editor: Given the number of women who are diagnosed with ovarian cancer each year (1) and the poor survival after diagnosis, the development of an effective screening method would clearly be of public health benefit. Therefore, the results of the study by Visintin et al. (2, 3) of a serum biomarker test for ovarian cancer with a reported sensitivity… CONTINUE READING